National Institutes of Health, National Institute on Drug Abuse (NIDA) Announcement of Requirements and Registration for “Addiction Research: There's an App for That” Challenge, 67773-67776 [2015-27939]
Download as PDF
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3222,
MSC 7808, Bethesda, MD 20892, (301) 435–
0628, newmanjh@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Child Psychopathology and
Developmental Disabilities.
Date: November 30, 2015.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Serena Chu, Ph.D.,
Scientific Review Officer, BBBP IRG, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–500–
5829, sechu@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 28, 2015.
Sylvia Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–27870 Filed 11–2–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health, National
Institute on Drug Abuse (NIDA)
Announcement of Requirements and
Registration for ‘‘Addiction Research:
There’s an App for That’’ Challenge
Authority: 15 U.S.C. 3719.
The National Institute on
Drug Abuse (NIDA), one of the
components of the National Institutes of
Health (NIH), announces the Challenge,
‘‘Addiction Research: There’s an App
for that’’. With this Challenge, NIDA
aims to develop novel mobile
applications (apps) for future addiction
research explicitly created on Apple
Inc.’s ResearchKit framework.
ResearchKit is open-source software
which makes it easy for researchers and
developers to create apps for specific
biomedical research questions by
circumventing development of custom
code. Contestants will create the
solicited app for use by addiction
researchers to engage mobile device
users in future society-changing
research.
Judging Period: May 2, 2016 to July
29, 2016.
Winners Announced: August 1, 2016.
FOR FURTHER INFORMATION CONTACT:
Elena Koustova, Ph.D., MBA, Director,
Office of Translational Initiatives and
Program Innovations (OTIPI), NIDA
Challenge Manager, National Institute
on Drug Abuse (NIDA), 6001 Executive
Blvd. Room 4286, MSC 9555 Bethesda,
MD 20892–9555 Phone: (301) 496–8768
Email: elena.koustova@nih.gov.
SUPPLEMENTARY INFORMATION:
The Institute’s Statutory Authority to
Conduct the Challenge. NIDA is
conducting this challenge under the
America Creating Opportunities to
Meaningfully Promote Excellence in
Technology, Education, and Science
(COMPETES) Reauthorization Act of
2010, 15 U.S.C. 3719. This Challenge is
consistent with and advances the
mission of NIDA as described in 42
U.S.C. 285o. The general purpose of
NIDA is to conduct and support
biomedical and behavioral research,
health-services research, research
training, and health-information
dissemination with respect to the
prevention of drug abuse and the
treatment of drug abusers. App
developed as a result of this Challenge
will help NIDA to gain strides in
behavioral addiction research. After
winning apps are selected, NIDA may
announce subsequent funding programs
for a future research study with real
human subjects to engage the widest
possible community of participants—
‘‘citizen scientists.’’ These future
research studies will help researchers to
better understand drug abuse and
addiction.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
Subject of Challenge
The Challenge begins November
3, 2015.
Submission Period: November 3, 2015
to April 29, 2016, 11:59 p.m., ET.
Background: The problem of drug
abuse affects almost every community
and family and yet it remains an
uncomfortable subject for discussion.
Each year, substance abuse causes high
rates of injuries and mortality among
Americans and plays a role in many
major social problems, such as drugged
driving, violence, child abuse, stress,
crime, and problems with employment.
It harms unborn babies, destroys
families, and contributes to
homelessness. The societal burden
caused by substance use disorders
exceeds half a trillion dollars yearly.
This cost to society is greater than other
chronic conditions such as diabetes
($131.7 billion) and cancer ($171.6
billion). NIDA sponsors the majority of
addiction-related scientific research in
the world. NIDA-funded researchers
seek to answer important scientific
questions about the paths people take to
DATES:
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
67773
avoid or to succumb to drug addiction,
about the mechanisms and pathways
involved in substance-use disorders,
and about new tools and techniques for
prevention and treatment.
Because the problems stemming from
drug abuse and addiction affect almost
every community and family to some
degree, NIDA issues this Challenge with
the hope that Contestants will actively
mobilize around the need to know more
about the roots of drug abuse and
addiction. Specifically, NIDA is seeking
to engage communities to envision and
to create an app which will help
advance scientific research in areas of
nicotine, opioids, cannabinoids
(including marijuana),
methamphetamines, and prescription
drug use. The Institute is also interested
in further understanding abstinence and
wellness as it relates to drug addiction.
The causes and consequences of
addiction are multi-faceted, involving
biological, behavioral, social, cultural,
economic, and environmental factors.
These factors likely interact, with no
single factor exerting substantial
independent influence on drug use and
addiction risk. Unfortunately, most
research addresses these factors
separately because it is difficult to
collect data on the large numbers of
participants needed to understand the
multi-factor relationships. However, this
is changing. Mobile technology offers
the capacity to recruit large numbers of
participants, in diverse and distant
places and to collect prospective data on
a broad range of variables as these study
participants go about their daily lives.
This approach has already led to
advances in addiction research. Mobile
assessment has extended to geolocation
and physiological monitoring, with
promising results for predicting and
detecting drug use in the field.
As exciting as these findings have
been, however, the scope of studies and
the types and number of participants
studied have been limited by
researchers’ access to mobile
technology. The problem has been
exacerbated by a gap in communication
between addiction researchers and
software and hardware developers. In
addition, NIDA-sponsored mobile tools
and technologies are often afflicted by a
lack of interoperability and by nonsustainability beyond the grant-funding
period.
Fortunately, those concerns can be
successfully addressed by the inventive
uses of customizable research platforms
developed by the established
informatics technology companies. The
recently unveiled ResearchKit
developed by Apple Inc. is the available
platform designed specifically for
E:\FR\FM\03NON1.SGM
03NON1
mstockstill on DSK4VPTVN1PROD with NOTICES
67774
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
biomedical research (https://www.apple.
com/researchkit/). NIDA’s choice of
ResearchKit as the platform does not
reflect any endorsement of Apple Inc.
and Apple’s products in the Challenge;
rather, it is a response to Apple’s release
of a set of tools specifically intended for
use in health research.
Challenge Goals: NIDA hopes this
Challenge will help to promote the
development of innovative research
apps created on Apple’s ResearchKit
framework for future addiction studies.
Research questions to be answered
could include, but are not limited to:
Would tracking lifestyle choices,
behaviors, nutrition, stress, social
participation, work, school, home,
neighborhood, genetics, exposure to
technology, etc. help to understand why
some people manage to stay away from
drug abuse and addiction? What
contributes to the choice to abuse
prescription drugs? How can we
systematically collect the experience of
patients recovering from addiction? Are
there innovative approaches to
recording patients’ experiences of
impact and burden of drug addiction
over time? Can the benefits of reduced
drug use be meaningfully detected? Can
we reveal and collect the participantidentified disease impacts and the
preferences for treatment impacts to
identify meaningful, significant,
perhaps, novel, and potential measures
of benefit?
It is critical to note that the apps
developed as a result of this Challenge
are to be explicitly created for future
scientific research purposes, and not for
self-help, education, or self-wellness
monitoring like other apps already
available on iTunes. The submissions
must not contain any data about real
people, and the Contestants must not
use data from or about real people in the
development or testing of the apps.
However, the app should be designed
such that it could be used in future
clinical research studies with real
human subjects.
Major ethical and legal issues that
have to be addressed at every step of the
way should include privacy (especially
in terms of the end-user’s experience as
he or she interacts with the app) and
confidentiality (the assurance that endusers’ data will be seen and used only
in the ways they want). Contestants are
responsible for developing and coding
the app so that its future use in a study
with real human research subjects
would be compliant with all applicable
federal, state, local, and institutional
laws, regulations, and policies. These
include, but are not limited to,
Substance Abuse Confidentiality
Regulations at 42 CFR part 2, Health
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
Information Portability and
Accountability Act (HIPAA) protections,
Department of Health and Human
Services (HHS) Protection of Human
Subjects regulations at 45 CFR part 46,
and Food and Drug Administration
(FDA) regulations.
Rules for Participating in the
Challenge. The Challenge is open to any
Contestant 13 years of age or older. A
Contestant may be (i) an entity or (ii) an
individual or group of individuals (i.e.,
a team assembled with the purpose of
participating in this Challenge), each of
whom is a U.S. citizen or permanent
resident of the United States.
Individuals who are younger than 18
must have their parent or legal guardian
complete the Parental Consent Form
found at https://www.drugabuse.gov/
sites/default/files/parental
consentform.pdf.
(1) To be eligible to win a prize under
this Challenge, an individual or entity:
a. Shall have registered to participate
in the Challenge under the rules
promulgated by NIDA as published in
this Notice;
b. Shall have complied with all the
requirements set forth in this Notice;
c. In the case of a private entity, shall
be incorporated in and maintain a
primary place of business in the United
States, and in the case of an individual,
whether participating singly or in a
group, shall be a citizen or permanent
resident of the United States. However,
non-U.S. citizens and non-permanent
residents can participate as a member of
a team that otherwise satisfies the
eligibility criteria. Non-U.S. citizens and
non-permanent residents are not eligible
to win a monetary prize (in whole or in
part). Their participation as part of a
winning team, if applicable, may be
otherwise recognized when the results
are announced.
d. May not be a Federal entity;
e. May not be a Federal employee
acting within the scope of the
employee’s employment and further, in
the case of HHS employees, may not
work on their submission(s) during
assigned duty hours;
f. May not be an employee of the NIH,
a judge of the challenge, or any other
party involved with the design,
production, execution, or distribution of
the Challenge or the immediate family
of such a party (i.e., spouse, parent,
step-parent, child, or step-child).
(2) Federal grantees may not use
Federal funds to develop their
Challenge submissions unless use of
such funds is consistent with the
purpose of their grant award and
specifically requested to do so due to
the Challenge design, and as announced
in the Federal Register.
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
(3) Federal contractors may not use
Federal funds from a contract to develop
their Challenge submissions or to fund
efforts in support of their Challenge
submission.
(4) Submissions must not infringe
upon any copyright or any other rights
of any third party. Each Contestant
warrants that he or she is the sole author
and owner of the work and that the
work is wholly original.
(5) By participating in this Challenge,
each Contestant (whether competing
singly or in a group) and entity agrees
to assume any and all risks and waive
claims against the Federal government
and its related entities (as defined in the
COMPETES Act), except in the case of
willful misconduct, for any injury,
death, damage, or loss of property,
revenue, or profits, whether direct,
indirect, or consequential, arising from
participation in this Challenge, whether
the injury, death, damage, or loss arises
through negligence or otherwise.
(6) Based on the subject matter of the
Challenge, the type of work that it will
possibly require, as well as an analysis
of the likelihood of any claims for death,
bodily injury, property damage, or loss
potentially resulting from Challenge
participation, no Contestant (whether
competing singly or in a group) or entity
participating in the Challenge is
required to obtain liability insurance or
demonstrate financial responsibility in
order to participate in this Challenge.
(7) By participating in this Challenge,
each Contestant (whether competing
singly or in a group) and entity agrees
to indemnify the Federal government
against third party claims for damages
arising from or related to Challenge
activities.
(8) A Contestant or entity shall not be
deemed ineligible because the
Contestant or entity used Federal
facilities or consulted with Federal
employees during the Challenge if the
facilities and employees are made
available to all individuals and entities
participating in the Challenge on an
equitable basis.
(9) By participating in this Challenge,
each Contestant (whether participating
singly or in a group) and entity grants
to the NIH/NIDA an irrevocable, paidup, royalty-free nonexclusive,
sublicensable worldwide license to post,
link to, share, use and display publicly
on the Web the submission, including
the architectural design of the app and
any other information necessary for a
third-party to use, adapt, improve or
otherwise modify the app. Each
Contestant will retain all other
intellectual property rights in their
submissions, as applicable.
E:\FR\FM\03NON1.SGM
03NON1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
(10) NIDA reserves the right, in its
sole discretion, to (a) cancel, suspend,
or modify the Challenge, (b) not award
any prizes if no entries are deemed
worthy, and (c) to disqualify from
competition any submission that
contains or uses data about real people
or is deemed, in the judging panel’s
discretion, inappropriate, offensive,
defamatory, or demeaning.
(11) Each Contestant (whether
participating singly or in a group) or
entity agrees to follow all applicable
federal, state, and local laws,
regulations, and policies.
(12) Each Contestant (whether
participating singly or in a group) and
entity participating in this Challenge
must comply with all terms and
conditions of these rules, and
participation in this Challenge
constitutes each such contestant’s full
and unconditional agreement to abide
by these rules. Winning is contingent
upon fulfilling all requirements herein.
Registration Process for Contestants.
To participate in this Challenge visit
https://nida.ideascale.com, a NIDA
Challenge platform provider.
Alternatively, visit www.challenge.gov
and search for ‘‘Addiction Research:
There’s an App for that’’ and follow the
instructions. NIDA encourages
established addiction researchers to
share the ideas via the Forum (https://
nida.ideascale.com) and seek
collaboration(s) with app developers
and engineers to create the winning
research apps.
Submission Requirements. All
submissions must be in English. The
Contestants must not use HHS’s logo or
official seal or the logo of NIH or NIDA
in the submissions, and must not claim
federal government endorsement.
Due to sensitivities surrounding
addictions information, only fictitious
data may be used for app development.
The submission must not contain any
data from or about real people, and the
Contestant must not use data from or
about real people in the development or
testing of the app. However, the app
should be designed such that it could be
used in future potential clinical research
studies with real human subjects.
Entries that include data from or about
real people will be disqualified.
Each submission for this Challenge
requires a complete ‘‘Submission
Package.’’ The Submission Package
includes:
(1) A white paper describing the app
built upon the proposed design of future
scientific research studies. The white
paper must describe a scientific research
agenda and study design that could be
undertaken using the developed app in
future human subject research.
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
Components of the white paper include,
but are not limited to:
a. Research design or conceptual
framework
b. Research agenda
c. Description of ResearchKit modules
and add-apters incorporated and
otherwise considered
d. Statement about compliance with
substance abuse and other applicable
laws and regulations
e. Data collection and management plan
f. Recruitment and retention advantages
of the proposed approach
The white paper must consist of a
PDF file, not contain any information
directly identifying the Contestants. The
PDF document must be formatted to be
no larger than 8.5″ by 11.0″, with at least
1 inch margins. The white paper must
be no more than 12 pages long. Font size
must be no smaller than 11 point Arial.
(2) A video of the app prototype. A
brief demo video (or its link to
YouTube) must be no more than five (5)
minutes and clearly demonstrate the
app functionality. The Contestant must
have permission to use all content in the
video, including footage, music and
images. The video must not contain any
information or images directly
identifying the Contestant.
(3) App software. The working
software must operate on a mobile
device using Apple’s ResearchKit
framework. The Contestants must
provide a way for the NIDA to test the
app such as a weblink, installation file,
or a shared test build. The submission
may be disqualified if the software
application fails to function as
expressed in the prototype description
submitted by the Contestant.
Amount of the Prize; Award
Approving Official. Up to three
monetary prizes will be awarded:
$50,000 for 1st Place, $30,000 for 2nd
Place, and $20,000 for 3rd Place for a
total prize award pool of up to $100,000.
The names of the winners and the titles
of their submissions will be posted on
the NIDA Web site. The award
approving official for this Challenge is
the Director of the National Institute on
Drug Abuse.
Payment of the Prize. Prizes awarded
under this Challenge will be paid by
electronic funds transfer and may be
subject to Federal income taxes. The
NIH/NIDA will comply with the
Internal Revenue Service withholding
and reporting requirements, where
applicable.
Basis Upon Which the Winner Will Be
Selected. The judging panel will make
recommendations to the award
approving official based upon the
following 8 criteria. Each criterion will
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
67775
be scored with the maximum of 5
points.
(1) Quality of the research agenda (0–
5 points): How well is the research
design or conceptual framework
developed? Is it unique and clinically
meaningful? Does the research agenda
describe a logical, feasible plan and
timeframe for addressing addiction
knowledge gaps?
(2) Proposed ResearchKit modules (0–
5 points): How many existing features of
the ResearchKit does the app use? How
are the modules applicable for
conducting future addiction research?
Does the Contestant consider creating
new modules?
(3) Add-apters (0–5 points): Does the
app utilize novel add-apters? How are
the proposed add-apters applicable to
the future research study?
(4) Compliance with applicable legal
policies. (0–5 points): Although the
competition requires that the
submission must not contain any
research data about real individuals,
and the Contestants must not use real
data in the development of the app, the
submission will be evaluated on
whether the app design and research
agenda would be compliant with all
applicable federal, state, local, and
institutional laws, regulations, and
policies. These include, but are not
limited to, Substance Abuse
Confidentiality Regulations at 42 CFR
part 2, HIPAA protections, HHS
Protection of Human Subjects
regulations at 45 CFR part 46, and FDA
regulations. Would the app ensure
compliance with consent requirements
for future potential addiction studies?
Would the app clearly explain study
participation to the user? Would data
management be safe and secure?
(5) Study participant’s engagement
(0–5 points): How well would the app
attract and retain human subject
engagement? Does it assure the high
level of human subject participation?
(6) Durability of study participation
(0–5 points): How reasonable is the plan
for retaining human subjects and data
collection over the duration of the
future, proposed research study?
(7) Clarity of the app context (0–5
points): Will the app provide a
transparent, engaging user experience
for both addiction researchers and
human subjects? Would the future
human subjects of research be able to
easily track their overall progress during
the research study? Would future
human subjects of research know what
information is being collected, why, and
what will happen with their data?
(8) Data quality for researchers (0–5
points): Is it easy for addiction
researchers to monitor and manage the
E:\FR\FM\03NON1.SGM
03NON1
67776
Federal Register / Vol. 80, No. 212 / Tuesday, November 3, 2015 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
overall progression of the research
study? Is the data management plan
appropriate? Are data clearly presented
to the researcher?
The evaluation process will begin by
anonymizing and removing those that
are not responsive to this Challenge or
not in compliance with all rules of
participation eligibility. Submissions
that are responsive and in compliance
will next undergo a review by federal
employees with expertise in the relevant
areas of science and executive scientific
advisors. A panel of judges consisting of
federal employees will then score
responsive and compliant submissions
entries in accordance with the judging
criteria outlined above. Final
recommendations will be determined by
a vote of the judges based on score.
Scores from each criterion will be
weighted equally, but failure to meet a
minimum standard for any one criterion
might disqualify an application. The
score for each submission will be the
sum of the scores from each of the 5
voting judges, for a maximum of 200
points.
Additional Information
What is ResearchKit? ResearchKit is
an open-source software kit designed
specifically for medical and health
research; it simplifies the creation of
iPhone apps that can help physicians
and scientists gather data from willing
participants. The framework allows
researchers to circumvent the
development of custom code for
common tasks such as sharing, storage,
and syncing of research data. It helps to
create apps to recruit human subjects in
research, present informed-consent
materials, create surveys and tasks, and
monitor sensors interoperable with
smartphone technology. ResearchKit
works seamlessly with Apple HealthKit,
a suite of applications that can interact
with the iPhone accelerometer,
microphone, gyroscope, GPS sensors,
and external hardware such as
glucometers, inhalers, and other existing
and newly developed sensors. These
capabilities could help monitor a
participant’s gait, motor impairment,
physical fitness, speech, and memory, to
name just a few. Additional hardware
extensions (add-apters) are frequently
developed and available.
It is important to note that the
ResearchKit framework does not include
a data management solution. The
framework can be used with a data
management solution only after IRB
approval of the human health study
with consideration of the provider’s
data privacy and security practices.
Apple’s ResearchKit debuted in March
2015 with five opt-in health research
VerDate Sep<11>2014
18:04 Nov 02, 2015
Jkt 238001
apps, now available for free public
download. For more information about
Apple’s ResearchKit and the developed
apps visit https://www.apple.com/
researchkit/ and https://
nida.ideascale.com.
Features and modules currently
accessible and compatible with Apple’s
ResearchKit: Apple’s iPhones have a
number of built-in sensors, including
Touch ID, Barometer, Accelerometer,
Gyroscope, Proximity Sensor, and
Ambient Light Sensor. The Touch ID is
a biometric technology that provides
user identification through a finger
scanner, the Barometer measures
atmospheric pressure, the
Accelerometer measure the tilting
motion and orientation of the iPhone,
and the Three-Axis Gyroscope enables
3-axis angular acceleration around the
X, Y and Z axes, enabling precise
calculation of yaw, pitch, and roll. The
Proximity Sensor deactivates the
display and touchscreen when the
phone is brought near the face during a
call and the Ambient Light Sensor
adjusts the display brightness. All
sensors are available for the iPhone 6
Plus, iPhone 6, iPhone 5S and iPhone 5.
The only exceptions are the Barometer
sensor, which is only available for the
iPhone 6 Plus, and iPhone 6, and the
Touch ID sensor, which is only
available for the iPhone 6 Plus, iPhone
6, and iPhone 5S.
In addition to internal sensors, there
are a number of add-apters which work
with existing iPhones. The add-apters
can measure pulse rate, breathing
pattern, blood pressure, blood oxygen
saturation, heart rate variability,
galvanic skin response, and glucose
concentration, and can even help detect
ear infections and track inhaler
medication use. Some add-adapters can
be directly purchased through iTunes or
third-party vendors; others must be
purchased through a physician. Based
on the type of adapter, prices can vary
from $6 to $249.
Dated: October 27, 2015.
Nora D. Volkow,
Director, National Institute on Drug Abuse,
National Institutes of Health.
[FR Doc. 2015–27939 Filed 11–2–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00079
Fmt 4703
Sfmt 9990
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Asthma, Pulmonary Fibrosis and
Inflammation.
Date: November 3–4, 2015.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Bradley Nuss, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4142,
MSC7814, Bethesda, MD 20892, 301–451–
8754, nussb@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA
Application in Infectious Diseases and
Microbiology.
Date: November 9, 2015.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, 301–996–
5819, zhengli@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 29, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–27984 Filed 11–2–15; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\03NON1.SGM
03NON1
Agencies
[Federal Register Volume 80, Number 212 (Tuesday, November 3, 2015)]
[Notices]
[Pages 67773-67776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-27939]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health, National Institute on Drug Abuse
(NIDA) Announcement of Requirements and Registration for ``Addiction
Research: There's an App for That'' Challenge
Authority: 15 U.S.C. 3719.
SUMMARY: The National Institute on Drug Abuse (NIDA), one of the
components of the National Institutes of Health (NIH), announces the
Challenge, ``Addiction Research: There's an App for that''. With this
Challenge, NIDA aims to develop novel mobile applications (apps) for
future addiction research explicitly created on Apple Inc.'s
ResearchKit framework. ResearchKit is open-source software which makes
it easy for researchers and developers to create apps for specific
biomedical research questions by circumventing development of custom
code. Contestants will create the solicited app for use by addiction
researchers to engage mobile device users in future society-changing
research.
DATES: The Challenge begins November 3, 2015.
Submission Period: November 3, 2015 to April 29, 2016, 11:59 p.m.,
ET.
Judging Period: May 2, 2016 to July 29, 2016.
Winners Announced: August 1, 2016.
FOR FURTHER INFORMATION CONTACT: Elena Koustova, Ph.D., MBA, Director,
Office of Translational Initiatives and Program Innovations (OTIPI),
NIDA Challenge Manager, National Institute on Drug Abuse (NIDA), 6001
Executive Blvd. Room 4286, MSC 9555 Bethesda, MD 20892-9555 Phone:
(301) 496-8768 Email: elena.koustova@nih.gov.
SUPPLEMENTARY INFORMATION:
The Institute's Statutory Authority to Conduct the Challenge. NIDA
is conducting this challenge under the America Creating Opportunities
to Meaningfully Promote Excellence in Technology, Education, and
Science (COMPETES) Reauthorization Act of 2010, 15 U.S.C. 3719. This
Challenge is consistent with and advances the mission of NIDA as
described in 42 U.S.C. 285o. The general purpose of NIDA is to conduct
and support biomedical and behavioral research, health-services
research, research training, and health-information dissemination with
respect to the prevention of drug abuse and the treatment of drug
abusers. App developed as a result of this Challenge will help NIDA to
gain strides in behavioral addiction research. After winning apps are
selected, NIDA may announce subsequent funding programs for a future
research study with real human subjects to engage the widest possible
community of participants--``citizen scientists.'' These future
research studies will help researchers to better understand drug abuse
and addiction.
Subject of Challenge
Background: The problem of drug abuse affects almost every
community and family and yet it remains an uncomfortable subject for
discussion. Each year, substance abuse causes high rates of injuries
and mortality among Americans and plays a role in many major social
problems, such as drugged driving, violence, child abuse, stress,
crime, and problems with employment. It harms unborn babies, destroys
families, and contributes to homelessness. The societal burden caused
by substance use disorders exceeds half a trillion dollars yearly. This
cost to society is greater than other chronic conditions such as
diabetes ($131.7 billion) and cancer ($171.6 billion). NIDA sponsors
the majority of addiction-related scientific research in the world.
NIDA-funded researchers seek to answer important scientific questions
about the paths people take to avoid or to succumb to drug addiction,
about the mechanisms and pathways involved in substance-use disorders,
and about new tools and techniques for prevention and treatment.
Because the problems stemming from drug abuse and addiction affect
almost every community and family to some degree, NIDA issues this
Challenge with the hope that Contestants will actively mobilize around
the need to know more about the roots of drug abuse and addiction.
Specifically, NIDA is seeking to engage communities to envision and to
create an app which will help advance scientific research in areas of
nicotine, opioids, cannabinoids (including marijuana),
methamphetamines, and prescription drug use. The Institute is also
interested in further understanding abstinence and wellness as it
relates to drug addiction.
The causes and consequences of addiction are multi-faceted,
involving biological, behavioral, social, cultural, economic, and
environmental factors. These factors likely interact, with no single
factor exerting substantial independent influence on drug use and
addiction risk. Unfortunately, most research addresses these factors
separately because it is difficult to collect data on the large numbers
of participants needed to understand the multi-factor relationships.
However, this is changing. Mobile technology offers the capacity to
recruit large numbers of participants, in diverse and distant places
and to collect prospective data on a broad range of variables as these
study participants go about their daily lives. This approach has
already led to advances in addiction research. Mobile assessment has
extended to geolocation and physiological monitoring, with promising
results for predicting and detecting drug use in the field.
As exciting as these findings have been, however, the scope of
studies and the types and number of participants studied have been
limited by researchers' access to mobile technology. The problem has
been exacerbated by a gap in communication between addiction
researchers and software and hardware developers. In addition, NIDA-
sponsored mobile tools and technologies are often afflicted by a lack
of interoperability and by non-sustainability beyond the grant-funding
period.
Fortunately, those concerns can be successfully addressed by the
inventive uses of customizable research platforms developed by the
established informatics technology companies. The recently unveiled
ResearchKit developed by Apple Inc. is the available platform designed
specifically for
[[Page 67774]]
biomedical research (https://www.apple.com/researchkit/). NIDA's choice
of ResearchKit as the platform does not reflect any endorsement of
Apple Inc. and Apple's products in the Challenge; rather, it is a
response to Apple's release of a set of tools specifically intended for
use in health research.
Challenge Goals: NIDA hopes this Challenge will help to promote the
development of innovative research apps created on Apple's ResearchKit
framework for future addiction studies. Research questions to be
answered could include, but are not limited to: Would tracking
lifestyle choices, behaviors, nutrition, stress, social participation,
work, school, home, neighborhood, genetics, exposure to technology,
etc. help to understand why some people manage to stay away from drug
abuse and addiction? What contributes to the choice to abuse
prescription drugs? How can we systematically collect the experience of
patients recovering from addiction? Are there innovative approaches to
recording patients' experiences of impact and burden of drug addiction
over time? Can the benefits of reduced drug use be meaningfully
detected? Can we reveal and collect the participant-identified disease
impacts and the preferences for treatment impacts to identify
meaningful, significant, perhaps, novel, and potential measures of
benefit?
It is critical to note that the apps developed as a result of this
Challenge are to be explicitly created for future scientific research
purposes, and not for self-help, education, or self-wellness monitoring
like other apps already available on iTunes. The submissions must not
contain any data about real people, and the Contestants must not use
data from or about real people in the development or testing of the
apps. However, the app should be designed such that it could be used in
future clinical research studies with real human subjects.
Major ethical and legal issues that have to be addressed at every
step of the way should include privacy (especially in terms of the end-
user's experience as he or she interacts with the app) and
confidentiality (the assurance that end-users' data will be seen and
used only in the ways they want). Contestants are responsible for
developing and coding the app so that its future use in a study with
real human research subjects would be compliant with all applicable
federal, state, local, and institutional laws, regulations, and
policies. These include, but are not limited to, Substance Abuse
Confidentiality Regulations at 42 CFR part 2, Health Information
Portability and Accountability Act (HIPAA) protections, Department of
Health and Human Services (HHS) Protection of Human Subjects
regulations at 45 CFR part 46, and Food and Drug Administration (FDA)
regulations.
Rules for Participating in the Challenge. The Challenge is open to
any Contestant 13 years of age or older. A Contestant may be (i) an
entity or (ii) an individual or group of individuals (i.e., a team
assembled with the purpose of participating in this Challenge), each of
whom is a U.S. citizen or permanent resident of the United States.
Individuals who are younger than 18 must have their parent or legal
guardian complete the Parental Consent Form found at https://www.drugabuse.gov/sites/default/files/parentalconsentform.pdf.
(1) To be eligible to win a prize under this Challenge, an
individual or entity:
a. Shall have registered to participate in the Challenge under the
rules promulgated by NIDA as published in this Notice;
b. Shall have complied with all the requirements set forth in this
Notice;
c. In the case of a private entity, shall be incorporated in and
maintain a primary place of business in the United States, and in the
case of an individual, whether participating singly or in a group,
shall be a citizen or permanent resident of the United States. However,
non-U.S. citizens and non-permanent residents can participate as a
member of a team that otherwise satisfies the eligibility criteria.
Non-U.S. citizens and non-permanent residents are not eligible to win a
monetary prize (in whole or in part). Their participation as part of a
winning team, if applicable, may be otherwise recognized when the
results are announced.
d. May not be a Federal entity;
e. May not be a Federal employee acting within the scope of the
employee's employment and further, in the case of HHS employees, may
not work on their submission(s) during assigned duty hours;
f. May not be an employee of the NIH, a judge of the challenge, or
any other party involved with the design, production, execution, or
distribution of the Challenge or the immediate family of such a party
(i.e., spouse, parent, step-parent, child, or step-child).
(2) Federal grantees may not use Federal funds to develop their
Challenge submissions unless use of such funds is consistent with the
purpose of their grant award and specifically requested to do so due to
the Challenge design, and as announced in the Federal Register.
(3) Federal contractors may not use Federal funds from a contract
to develop their Challenge submissions or to fund efforts in support of
their Challenge submission.
(4) Submissions must not infringe upon any copyright or any other
rights of any third party. Each Contestant warrants that he or she is
the sole author and owner of the work and that the work is wholly
original.
(5) By participating in this Challenge, each Contestant (whether
competing singly or in a group) and entity agrees to assume any and all
risks and waive claims against the Federal government and its related
entities (as defined in the COMPETES Act), except in the case of
willful misconduct, for any injury, death, damage, or loss of property,
revenue, or profits, whether direct, indirect, or consequential,
arising from participation in this Challenge, whether the injury,
death, damage, or loss arises through negligence or otherwise.
(6) Based on the subject matter of the Challenge, the type of work
that it will possibly require, as well as an analysis of the likelihood
of any claims for death, bodily injury, property damage, or loss
potentially resulting from Challenge participation, no Contestant
(whether competing singly or in a group) or entity participating in the
Challenge is required to obtain liability insurance or demonstrate
financial responsibility in order to participate in this Challenge.
(7) By participating in this Challenge, each Contestant (whether
competing singly or in a group) and entity agrees to indemnify the
Federal government against third party claims for damages arising from
or related to Challenge activities.
(8) A Contestant or entity shall not be deemed ineligible because
the Contestant or entity used Federal facilities or consulted with
Federal employees during the Challenge if the facilities and employees
are made available to all individuals and entities participating in the
Challenge on an equitable basis.
(9) By participating in this Challenge, each Contestant (whether
participating singly or in a group) and entity grants to the NIH/NIDA
an irrevocable, paid-up, royalty-free nonexclusive, sublicensable
worldwide license to post, link to, share, use and display publicly on
the Web the submission, including the architectural design of the app
and any other information necessary for a third-party to use, adapt,
improve or otherwise modify the app. Each Contestant will retain all
other intellectual property rights in their submissions, as applicable.
[[Page 67775]]
(10) NIDA reserves the right, in its sole discretion, to (a)
cancel, suspend, or modify the Challenge, (b) not award any prizes if
no entries are deemed worthy, and (c) to disqualify from competition
any submission that contains or uses data about real people or is
deemed, in the judging panel's discretion, inappropriate, offensive,
defamatory, or demeaning.
(11) Each Contestant (whether participating singly or in a group)
or entity agrees to follow all applicable federal, state, and local
laws, regulations, and policies.
(12) Each Contestant (whether participating singly or in a group)
and entity participating in this Challenge must comply with all terms
and conditions of these rules, and participation in this Challenge
constitutes each such contestant's full and unconditional agreement to
abide by these rules. Winning is contingent upon fulfilling all
requirements herein.
Registration Process for Contestants. To participate in this
Challenge visit https://nida.ideascale.com, a NIDA Challenge platform
provider. Alternatively, visit www.challenge.gov and search for
``Addiction Research: There's an App for that'' and follow the
instructions. NIDA encourages established addiction researchers to
share the ideas via the Forum (https://nida.ideascale.com) and seek
collaboration(s) with app developers and engineers to create the
winning research apps.
Submission Requirements. All submissions must be in English. The
Contestants must not use HHS's logo or official seal or the logo of NIH
or NIDA in the submissions, and must not claim federal government
endorsement.
Due to sensitivities surrounding addictions information, only
fictitious data may be used for app development. The submission must
not contain any data from or about real people, and the Contestant must
not use data from or about real people in the development or testing of
the app. However, the app should be designed such that it could be used
in future potential clinical research studies with real human subjects.
Entries that include data from or about real people will be
disqualified.
Each submission for this Challenge requires a complete ``Submission
Package.'' The Submission Package includes:
(1) A white paper describing the app built upon the proposed design
of future scientific research studies. The white paper must describe a
scientific research agenda and study design that could be undertaken
using the developed app in future human subject research. Components of
the white paper include, but are not limited to:
a. Research design or conceptual framework
b. Research agenda
c. Description of ResearchKit modules and add-apters incorporated and
otherwise considered
d. Statement about compliance with substance abuse and other applicable
laws and regulations
e. Data collection and management plan
f. Recruitment and retention advantages of the proposed approach
The white paper must consist of a PDF file, not contain any
information directly identifying the Contestants. The PDF document must
be formatted to be no larger than 8.5'' by 11.0'', with at least 1 inch
margins. The white paper must be no more than 12 pages long. Font size
must be no smaller than 11 point Arial.
(2) A video of the app prototype. A brief demo video (or its link
to YouTube) must be no more than five (5) minutes and clearly
demonstrate the app functionality. The Contestant must have permission
to use all content in the video, including footage, music and images.
The video must not contain any information or images directly
identifying the Contestant.
(3) App software. The working software must operate on a mobile
device using Apple's ResearchKit framework. The Contestants must
provide a way for the NIDA to test the app such as a weblink,
installation file, or a shared test build. The submission may be
disqualified if the software application fails to function as expressed
in the prototype description submitted by the Contestant.
Amount of the Prize; Award Approving Official. Up to three monetary
prizes will be awarded: $50,000 for 1st Place, $30,000 for 2nd Place,
and $20,000 for 3rd Place for a total prize award pool of up to
$100,000. The names of the winners and the titles of their submissions
will be posted on the NIDA Web site. The award approving official for
this Challenge is the Director of the National Institute on Drug Abuse.
Payment of the Prize. Prizes awarded under this Challenge will be
paid by electronic funds transfer and may be subject to Federal income
taxes. The NIH/NIDA will comply with the Internal Revenue Service
withholding and reporting requirements, where applicable.
Basis Upon Which the Winner Will Be Selected. The judging panel
will make recommendations to the award approving official based upon
the following 8 criteria. Each criterion will be scored with the
maximum of 5 points.
(1) Quality of the research agenda (0-5 points): How well is the
research design or conceptual framework developed? Is it unique and
clinically meaningful? Does the research agenda describe a logical,
feasible plan and timeframe for addressing addiction knowledge gaps?
(2) Proposed ResearchKit modules (0-5 points): How many existing
features of the ResearchKit does the app use? How are the modules
applicable for conducting future addiction research? Does the
Contestant consider creating new modules?
(3) Add-apters (0-5 points): Does the app utilize novel add-apters?
How are the proposed add-apters applicable to the future research
study?
(4) Compliance with applicable legal policies. (0-5 points):
Although the competition requires that the submission must not contain
any research data about real individuals, and the Contestants must not
use real data in the development of the app, the submission will be
evaluated on whether the app design and research agenda would be
compliant with all applicable federal, state, local, and institutional
laws, regulations, and policies. These include, but are not limited to,
Substance Abuse Confidentiality Regulations at 42 CFR part 2, HIPAA
protections, HHS Protection of Human Subjects regulations at 45 CFR
part 46, and FDA regulations. Would the app ensure compliance with
consent requirements for future potential addiction studies? Would the
app clearly explain study participation to the user? Would data
management be safe and secure?
(5) Study participant's engagement (0-5 points): How well would the
app attract and retain human subject engagement? Does it assure the
high level of human subject participation?
(6) Durability of study participation (0-5 points): How reasonable
is the plan for retaining human subjects and data collection over the
duration of the future, proposed research study?
(7) Clarity of the app context (0-5 points): Will the app provide a
transparent, engaging user experience for both addiction researchers
and human subjects? Would the future human subjects of research be able
to easily track their overall progress during the research study? Would
future human subjects of research know what information is being
collected, why, and what will happen with their data?
(8) Data quality for researchers (0-5 points): Is it easy for
addiction researchers to monitor and manage the
[[Page 67776]]
overall progression of the research study? Is the data management plan
appropriate? Are data clearly presented to the researcher?
The evaluation process will begin by anonymizing and removing those
that are not responsive to this Challenge or not in compliance with all
rules of participation eligibility. Submissions that are responsive and
in compliance will next undergo a review by federal employees with
expertise in the relevant areas of science and executive scientific
advisors. A panel of judges consisting of federal employees will then
score responsive and compliant submissions entries in accordance with
the judging criteria outlined above. Final recommendations will be
determined by a vote of the judges based on score. Scores from each
criterion will be weighted equally, but failure to meet a minimum
standard for any one criterion might disqualify an application. The
score for each submission will be the sum of the scores from each of
the 5 voting judges, for a maximum of 200 points.
Additional Information
What is ResearchKit? ResearchKit is an open-source software kit
designed specifically for medical and health research; it simplifies
the creation of iPhone apps that can help physicians and scientists
gather data from willing participants. The framework allows researchers
to circumvent the development of custom code for common tasks such as
sharing, storage, and syncing of research data. It helps to create apps
to recruit human subjects in research, present informed-consent
materials, create surveys and tasks, and monitor sensors interoperable
with smartphone technology. ResearchKit works seamlessly with Apple
HealthKit, a suite of applications that can interact with the iPhone
accelerometer, microphone, gyroscope, GPS sensors, and external
hardware such as glucometers, inhalers, and other existing and newly
developed sensors. These capabilities could help monitor a
participant's gait, motor impairment, physical fitness, speech, and
memory, to name just a few. Additional hardware extensions (add-apters)
are frequently developed and available.
It is important to note that the ResearchKit framework does not
include a data management solution. The framework can be used with a
data management solution only after IRB approval of the human health
study with consideration of the provider's data privacy and security
practices. Apple's ResearchKit debuted in March 2015 with five opt-in
health research apps, now available for free public download. For more
information about Apple's ResearchKit and the developed apps visit
https://www.apple.com/researchkit/ and https://nida.ideascale.com.
Features and modules currently accessible and compatible with
Apple's ResearchKit: Apple's iPhones have a number of built-in sensors,
including Touch ID, Barometer, Accelerometer, Gyroscope, Proximity
Sensor, and Ambient Light Sensor. The Touch ID is a biometric
technology that provides user identification through a finger scanner,
the Barometer measures atmospheric pressure, the Accelerometer measure
the tilting motion and orientation of the iPhone, and the Three-Axis
Gyroscope enables 3-axis angular acceleration around the X, Y and Z
axes, enabling precise calculation of yaw, pitch, and roll. The
Proximity Sensor deactivates the display and touchscreen when the phone
is brought near the face during a call and the Ambient Light Sensor
adjusts the display brightness. All sensors are available for the
iPhone 6 Plus, iPhone 6, iPhone 5S and iPhone 5. The only exceptions
are the Barometer sensor, which is only available for the iPhone 6
Plus, and iPhone 6, and the Touch ID sensor, which is only available
for the iPhone 6 Plus, iPhone 6, and iPhone 5S.
In addition to internal sensors, there are a number of add-apters
which work with existing iPhones. The add-apters can measure pulse
rate, breathing pattern, blood pressure, blood oxygen saturation, heart
rate variability, galvanic skin response, and glucose concentration,
and can even help detect ear infections and track inhaler medication
use. Some add-adapters can be directly purchased through iTunes or
third-party vendors; others must be purchased through a physician.
Based on the type of adapter, prices can vary from $6 to $249.
Dated: October 27, 2015.
Nora D. Volkow,
Director, National Institute on Drug Abuse, National Institutes of
Health.
[FR Doc. 2015-27939 Filed 11-2-15; 8:45 am]
BILLING CODE 4140-01-P